TRAIL: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(15 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{STRUCTURE_1d0g|  PDB=1d0g | SIZE=400| SCENE= |right|CAPTION=Human TRAIL trimer residues 114-281 (grey, light green, yellow) complex with death receptor-5 extracellular domain (dark blue, dark green, olive), Zn+2 (grey) and Cl-1 (green) ions, [[1d0g]] }}
<StructureSection load='1d0g' size='340' side='right' caption='Human TRAIL trimer residues 114-281 (grey, light green, yellow) complex with death receptor-5 extracellular domain (dark blue, dark green, olive), Zn+2 (grey) and Cl-1 (green) ions, [[1d0g]]' scene='' pspeed='8'>
== Function ==
'''TRAIL (TNF-related apoptosis-inducing ligand)''' or '''TNF ligand superfamily 10''' functions as a ligand in the process of apoptosis<ref>PMID:15987601</ref>. TRAIL binds to death receptors DR4, DR5, DcR1 and DcR2.  For details see [[Molecular Playground/TRAIL]]. '''TRAIL-R2''' is called '''DR5'''. <scene name='48/480878/Cv/3'>TRAIL trimer residues complex with death receptor-5 extracellular domain</scene> ([[1d0g]]). <scene name='48/480878/Cv/4'>Zn+2 and Cl-1 bind to 3 same Cys residues from different subunits of TRAIL trimer</scene>.


'''TRAIL (TNF-related apoptosis-inducing ligand)''' functions as a ligand in the process of apoptosis.  TRAIL binds to death receptors DR4, DR5, DcR1 and DcR2.  For details see [[Molecular Playground/TRAIL]].
See also:
 
*[[Cytokine receptors]]
{{TOC limit|limit=2}}
*[[Immune receptors]]


== Disease ==
TRAIL concentrations are reduced in rheumatoid arthritis<ref>PMID:25962765</ref>.
</StructureSection>
== 3D Structures of TRAIL ==
== 3D Structures of TRAIL ==
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}


[[1drv]] hTRAIL + DR5 extracellular domain – human<br />
TRAIL-R2 domains – extracellular 54-184; transmembrane 208-242
[[1d0g]] - hTRAIL residues 114-281 + DR5 extracellular domain<br />
[[1dg6]] – hTRAIL jelly-roll domain<br />
[[1d2q]] - hTRAIL extracellular domain


[[1d0g]], [[1d4v]], [[1du3]], [[5cir]] - hTRAIL 114-281 + TRAIL-R2 extracellular domain - human<br />
[[4n90]] - hTRAIL 114-281 + hTRAIL-R2 extracellular domain + antibody<br />
[[1dg6]] – hTRAIL jelly-roll domain 91-281<br />
[[1d2q]] - hTRAIL 114-281<br />
[[4i9x]] – hTRAIL-R2 extracellular domain + UL141<br />
[[3x3f]], [[1za3]], [[4od2]], [[2h9g]], [[6t3j]] – hTRAIL-R2 extracellular domain + antibody<br />
[[6nhw]] – hTRAIL-R2 transmembrane domain - NMR<br />
[[6nhy]] – hTRAIL-R2 transmembrane domain (mutant) - NMR<br />
== References ==
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Latest revision as of 10:51, 12 January 2023

Function

TRAIL (TNF-related apoptosis-inducing ligand) or TNF ligand superfamily 10 functions as a ligand in the process of apoptosis[1]. TRAIL binds to death receptors DR4, DR5, DcR1 and DcR2. For details see Molecular Playground/TRAIL. TRAIL-R2 is called DR5. (1d0g). .

See also:

Disease

TRAIL concentrations are reduced in rheumatoid arthritis[2].

Human TRAIL trimer residues 114-281 (grey, light green, yellow) complex with death receptor-5 extracellular domain (dark blue, dark green, olive), Zn+2 (grey) and Cl-1 (green) ions, 1d0g

Drag the structure with the mouse to rotate

3D Structures of TRAIL3D Structures of TRAIL

Updated on 12-January-2023

TRAIL-R2 domains – extracellular 54-184; transmembrane 208-242

1d0g, 1d4v, 1du3, 5cir - hTRAIL 114-281 + TRAIL-R2 extracellular domain - human
4n90 - hTRAIL 114-281 + hTRAIL-R2 extracellular domain + antibody
1dg6 – hTRAIL jelly-roll domain 91-281
1d2q - hTRAIL 114-281
4i9x – hTRAIL-R2 extracellular domain + UL141
3x3f, 1za3, 4od2, 2h9g, 6t3j – hTRAIL-R2 extracellular domain + antibody
6nhw – hTRAIL-R2 transmembrane domain - NMR
6nhy – hTRAIL-R2 transmembrane domain (mutant) - NMR

ReferencesReferences

  1. Daniels RA, Turley H, Kimberley FC, Liu XS, Mongkolsapaya J, Ch'En P, Xu XN, Jin BQ, Pezzella F, Screaton GR. Expression of TRAIL and TRAIL receptors in normal and malignant tissues. Cell Res. 2005 Jun;15(6):430-8. PMID:15987601 doi:http://dx.doi.org/10.1038/sj.cr.7290311
  2. Dessein PH, Lopez-Mejias R, Ubilla B, Genre F, Corrales A, Hernandez JL, Ferraz-Amaro I, Tsang L, Pina T, Llorca J, Blanco R, Gonzalez-Juanatey C, Gonzalez-Gay MA. TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis. Clin Exp Rheumatol. 2015 Jul-Aug;33(4):491-7. Epub 2015 May 11. PMID:25962765

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky